Inorganic nanomaterials that have inherently exceptional physicochemical properties (eg,
catalytic, optical, thermal, electrical, or magnetic performance) that can provide desirable …

In recent years, much progress has been motivated in stimuli-responsive nanocarriers,
which could response to the intrinsic physicochemical and pathological factors in diseased …

Ultrasmall gold nanoclusters (AuNCs) have emerged as agile probes for in vivo imaging, as
they exhibit exceptional tumour accumulation and efficient renal clearance properties …

Despite the progress achieved in nanomedicine during the last decade, the translation of
new nanotechnology‐based therapeutic systems into clinical applications has been slow …

Wearable transdermal delivery systems have recently received tremendous attention due to
their noninvasive, convenient, and prolonged administration of pharmacological agents …

Medical science has recently advanced to the point where diagnosis and therapeutics can
be carried out with high precision, even at the molecular level. A new field of “precision …

Reactive oxygen species (ROS)-sensitive drug delivery systems (DDS) specifically
responding to altered levels of ROS in the pathological microenvironment have emerged as …

Cancer metastasis requires the invasion of tumor cells into the stroma and the directed
migration of tumor cells through the stroma toward the vasculature and lymphatics where …

We are in the midst of a technological revolution that is providing new insights into human
biology and cancer. In this era of big data, we are amassing large amounts of information …

The complex tumor microenvironment is a most important factor in cancer development. The
biological microenvironment is composed of a variety of barriers including the extracellular …